Market LIVE
Published markets; coverage varies by country
Product profile · United States

LYNKUET

 ·  Patent Litigation & Settlement History ↓

IngredientELINZANETANT
Application typeNDA
Application219469
Product001
Dosage formCAPSULE
RouteORAL
Strength60MG
Approval date2025-10-24
Marketing statusPrescription
Status event—
ApplicantBAYER HLTHCARE
Product source

Current GenericRadar decision

Year2036
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeDS_EQUIVALENT_PATENT
Anchor date2036-05-18
Patent anchor2036-05-18
Exclusivity anchor2030-10-24
Protection date2045-05-14
First Final ANDA—
Status event—

ANCHOR_WITH_TAIL; US:NDA:219469:001; exact Final ANDA not verified; not proof of generic absence

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
76830562027-09-15DS/DP —YNTRUE_DS
| B1C03 issued-claim review2026-10-15: TRUE_DS
———
76830562027-09-15ORANGE_BOOK —YNTRUE_DS
English description not available.
———
101952052036-05-18U U-3622NYU
| B1C03 issued-claim review2026-10-15: U
———
101952052036-05-18ORANGE_BOOK U-3622NYU
English description not available.
———
107740912039-03-13DP —NNDP
| B1C03 issued-claim review2026-10-15: DP
———
107740912039-03-13ORANGE_BOOK —NNDP
English description not available.
———
117878202039-03-13U U-3622NNU
| B1C03 issued-claim review2026-10-15: U
———
117878202039-03-13ORANGE_BOOK U-3622NNU
English description not available.
———
122641642039-03-13U U-3622NNU
| B1C03 issued-claim review2026-10-15: U
———
122641642039-03-13ORANGE_BOOK U-3622NNU
English description not available.
———
125333582045-05-14U U-4402NNU
| B1C03 issued-claim review2026-10-15: U
———
125333582045-05-14ORANGE_BOOK U-4402NNU
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2025-10-242030-10-24English description not available.YY2030-10-24—Source
NCE2025-10-242030-10-24English description not available.YY2030-10-24
NCE
Full coverage date: 2030-10-24
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (8)
TypeDateRoleBasisSource
PATENT2027-09-15HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2036-05-18CANONICAL_ANCHOREnglish description not available.Source
PATENT2039-03-13FTO_TAILEnglish description not available.Source
PATENT2039-03-13FTO_TAILEnglish description not available.Source
PATENT2039-03-13FTO_TAILEnglish description not available.Source
PATENT2045-05-14FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2036-05-18CANONICAL_DECISIONANCHOR_WITH_TAIL; US:NDA:219469:001; exact Final ANDA not verified; not proof of generic absenceSource
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.